GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (FRA:DPM) » Definitions » Cyclically Adjusted PB Ratio

Sumitomo Pharma Co (FRA:DPM) Cyclically Adjusted PB Ratio : 0.23 (As of Jun. 01, 2024)


View and export this data going back to . Start your Free Trial

What is Sumitomo Pharma Co Cyclically Adjusted PB Ratio?

As of today (2024-06-01), Sumitomo Pharma Co's current share price is €1.77. Sumitomo Pharma Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €7.71. Sumitomo Pharma Co's Cyclically Adjusted PB Ratio for today is 0.23.

The historical rank and industry rank for Sumitomo Pharma Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:DPM' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.23   Med: 1.43   Max: 3.7
Current: 0.23

During the past years, Sumitomo Pharma Co's highest Cyclically Adjusted PB Ratio was 3.70. The lowest was 0.23. And the median was 1.43.

FRA:DPM's Cyclically Adjusted PB Ratio is ranked better than
91.72% of 725 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs FRA:DPM: 0.23

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sumitomo Pharma Co's adjusted book value per share data for the three months ended in Mar. 2024 was €2.412. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €7.71 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sumitomo Pharma Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Sumitomo Pharma Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Cyclically Adjusted PB Ratio Chart

Sumitomo Pharma Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.30 1.71 1.00 0.62 0.31

Sumitomo Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.62 0.49 0.41 0.35 0.31

Competitive Comparison of Sumitomo Pharma Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sumitomo Pharma Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's Cyclically Adjusted PB Ratio falls into.



Sumitomo Pharma Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Sumitomo Pharma Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.77/7.71
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sumitomo Pharma Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Sumitomo Pharma Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.412/107.2000*107.2000
=2.412

Current CPI (Mar. 2024) = 107.2000.

Sumitomo Pharma Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 7.190 98.000 7.865
201409 7.636 98.500 8.310
201412 7.737 97.900 8.472
201503 8.712 97.900 9.540
201506 8.306 98.400 9.049
201509 8.503 98.500 9.254
201512 8.891 98.100 9.716
201603 7.797 97.900 8.538
201606 9.055 98.100 9.895
201609 9.228 98.000 10.094
201612 9.744 98.400 10.615
201703 8.592 98.100 9.389
201706 9.537 98.500 10.379
201709 9.456 98.800 10.260
201712 9.729 99.400 10.492
201803 8.714 99.200 9.417
201806 9.158 99.200 9.897
201809 9.450 99.900 10.141
201812 9.820 99.700 10.559
201903 9.984 99.700 10.735
201906 10.088 99.800 10.836
201909 10.874 100.100 11.645
201912 10.795 100.500 11.515
202003 11.270 100.300 12.045
202006 11.241 99.900 12.062
202009 10.999 99.900 11.803
202012 10.907 99.300 11.775
202103 11.293 99.900 12.118
202106 10.892 99.500 11.735
202109 11.309 100.100 12.111
202112 11.757 100.100 12.591
202203 11.716 101.100 12.423
202206 11.962 101.800 12.597
202209 11.464 103.100 11.920
202212 11.186 104.100 11.519
202303 7.154 104.400 7.346
202306 6.853 105.200 6.983
202309 6.572 106.200 6.634
202312 5.507 106.800 5.528
202403 2.412 107.200 2.412

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sumitomo Pharma Co  (FRA:DPM) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Sumitomo Pharma Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sumitomo Pharma Co (FRA:DPM) Business Description

Traded in Other Exchanges
Address
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Sumitomo Pharma Co (FRA:DPM) Headlines